MetaTech Biomed

MetaTech (Biomed) is a Taiwan-based biotechnology company specializing in regenerative medicine and the distribution of electronic components and medical equipment. The company is best known for its collaboration with Japan's CellSeed to develop and commercialize cell sheet engineering technology, which involves harvesting a patient's own cells to create transplantable tissues. Its primary clinical focuses include esophageal regeneration and knee cartilage repair. MetaTech operates a high-standard GfP (Good Cell Practice) facility to support its cell therapy manufacturing and clinical trials. The company is publicly traded on the Taipei Exchange and continues to expand its footprint in the Asian regenerative medicine market.